Announcements Trials

Browse Landscape

Phase

Phase 2 124 Phase 1 103 Phase 3 34 Phase 1/2 24 Phase NA 17 Phase EARLY_PHASE1 1 Phase 4 1

Status

Sponsor Class

OTHER 24 INDUSTRY 8 OTHER_GOV 2 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Rectal Neoplasms 2 Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Anemia 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Smoking Cessation 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Pain 1 Neutropenia 1 Neurotoxicity Syndromes 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1 Lymphoma 1 Hypothyroidism 1 Human Papillomavirus-Related Cervical Carcinoma 1 Hepatitis C, Chronic 1 Hepatitis C 1 Gastrointestinal Stromal Tumors 1 Gallbladder Neoplasms 1 Fibrosis 1 Fatigue 1 Esophageal Neoplasms 1 Drug-Related Side Effects and Adverse Reactions 1 Diabetes Mellitus 1

Interventions

fluarix 1 arexvy 1 abrysvo 1 Influenza Vaccines 1 Heplisav-B 1 FluLaval 1 BNT162 Vaccine 1 Afluria 1 23-valent pneumococcal capsular polysaccharide vaccine 1 13-valent pneumococcal vaccine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × NIH × Lymphoma × Clear all

NCT05170399 2026-02-05

Vaccine Responses in Patients With B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 4 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡